At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The partnership is announced at Aero India 2023, Bangalore
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Advanz Pharma will leverage its specialty, hospital, and rare disease expertise and infrastructure to commercialize AT-007 in Europe for both Galactosemia and SORD Deficiency
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Subscribe To Our Newsletter & Stay Updated
